Clinical Trials Directory

Trials / Conditions / Male Urogenital Diseases

Male Urogenital Diseases

14 registered clinical trials studyying Male Urogenital Diseases — 8 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingBioengineered Penile Tissue Constructs for Irreversibly Damaged Penile Corpora
NCT03463239
Wake Forest University Health SciencesPhase 1
RecruitingSafety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures
NCT03258658
Wake Forest University Health SciencesPhase 1
RecruitingThe Radium-select Study
NCT06659926
The Netherlands Cancer InstituteN/A
RecruitingOpen-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617
NCT06785636
Pathos AI, Inc.Phase 1 / Phase 2
Recruiting18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prost
NCT06706921
VA Greater Los Angeles Healthcare SystemPhase 4
RecruitingVorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
NCT06676527
Jinling Hospital, China—
RecruitingCarboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer
NCT06353906
The Netherlands Cancer InstitutePhase 2
RecruitingStage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab
NCT06237920
The Netherlands Cancer InstitutePhase 2
UnknownOffice Based Transperineal Laser Ablation for Benign Prostatic Hyperplasia HYPERPLASIA
NCT04760483
Urological Research Network, LLCPhase 1
UnknownEarly Oxybutinin Treatment for Boys With Posterior Urethral Valves
NCT04526353
University Hospital, BordeauxPhase 2
CompletedIntraoperative Nerve Monitoring During Robotic-assisted Radical Prostatectomy
NCT03721029
Herlev and Gentofte HospitalN/A
CompletedComparison of Gas Consumption From Two Different Anesthesia Machines
NCT02774031
St. Olavs HospitalN/A
UnknownProstate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia
NCT02592473
University of VirginiaN/A
CompletedIdentification of Underlying Conditions in Men Prescribed a PDE5 Inhibitor
NCT01150903
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.—